×
Back to Agenda
LS01 Future Directions Based on Experience Developing Drugs to Treat Novel Coronavirus Infections
Session Chair(s)
Kanji Hirai, RPH
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt, MSD K.K., Japan
Speaker(s)
Hiroko Kawaguchi
Director, Regulatory Affairs, MSD, Japan
Hirofumi Sone
Manager, Japan Regulatory Lead, Regulatory Affairs, Pfizer R&D Japan, Japan
Yuji Arakawa
, Ministry of Health, Labour and Welfare (MHLW), Japan
Have an account?